Dr. András Komáromy is a professor of comparative ophthalmology, a board-certified veterinary ophthalmologist, and a vision scientist with a special interest in glaucoma at Michigan State University (MSU). After obtaining his veterinary degree from the University of Zurich, he received a PhD in comparative ophthalmology and glaucomatology at the University of Florida, where he also went through his clinical residency training. As a post-doctoral fellow and assistant professor at the University of Pennsylvania, he focused on developing novel retinal gene therapies, most notably for achromatopsia. Following his move to MSU, Dr. Komáromy started to focus again on the study of canine glaucoma and its value as a model for a better understanding of disease mechanisms that are likewise involved in human glaucoma. The development of novel gene therapies continues to be a central interest with their potential for effective, long-term intraocular pressure control and protection of the optic nerve. Dr. Komáromy is a recipient of the Shaffer Prize for Innovative Science (Glaucoma Research Foundation) and the Carl Camras Translational Research Award (ARVO Foundation/Pfizer Ophthalmics). He is a Fellow of the Association for Research in Vision and Ophthalmology (ARVO). Dr. Komáromy served on the board and as president of the American College of Veterinary Ophthalmologists (ACVO). He is the current Editor-in-Chief of Veterinary Ophthalmology.
András Komáromy, DVM, PhD
First published on: August 28, 2017
Last modified on: November 04, 2024